Navigation Links
Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
Date:5/16/2008

WEIFANG, Shandong, China, May 16 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today reported financial results for the three months ended March 31, 2008.

Third Quarter of Fiscal 2008 Highlights

-- Sales increased 64.8% to $20.7 million

-- Gross profit rose 37.2% to $4.5 million

-- Gross profit margin was 21.7%

-- Operating income increased 30.4% to $2.9 million

-- Net income increased 5.2% to $ 1.9 million

-- Weighted avg. diluted shares outstanding were 19.8 million vs. 10.1

million

-- Fully diluted EPS was $0.10 versus $0.18

Third Quarter of Fiscal 2008 Results

For the third quarter of fiscal 2008, sales increased 64.8% to $20.7 million from $12.6 million for the third quarter of fiscal 2007.

Cornstarch sales were $7.1 million in this quarter, up 212.5% from $2.3 million in the same period of 2007, sales of glucose products were $7.9 million in this quarter, down 4.3% from $8.3 million in the same period of 2007 and sales of other products were $5.6 million, up 177.5% from $2.0 million in the same period of 2007.

The increased sales of cornstarch resulted in a higher proportion of total cornstarch sales compared to the same reporting period last year. Along with an improving utilization rate of the new cornstarch manufacturing plant, the Company manufactured and sold more cornstarch with lower gross profit margins to generate necessary working capital and funds for construction of its new glucose complex. The significant growth of its other products business was mainly attributable to more sales of higher margin sodium gluconate and cornstarch byproducts associated with the greater operational size of the cornstarch business.

"The sales kept growing during this quarter
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
2. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. to Present at Roth Conference
4. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
5. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
6. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
7. China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc.
8. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
9. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
10. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... April 18, 2015 More than 2000 ... now at TheCelebrityDresses.com, the #1 online store carrying celebrity ... many girls have got their perfect dresses for their ... celebrity fashion prom dresses at TheCelebrityDresses.com would be an ... more than 2000 prom dresses inspired by the most ...
(Date:4/18/2015)... York, NY (PRWEB) April 18, 2015 On ... Internal Security Threat Report , which they say, “exposes a ... how many new malware variants were introduced in 2014 - ... took for Zero Day threats to be identified and patched ... it is abundantly clear that doing business in a digital ...
(Date:4/18/2015)... 18, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Carolina Physical Therapy Association Annual Conference to be ... in Greenville, SC. , The SCAPTA Annual ... with products and services. , Representatives from ...
(Date:4/18/2015)... ” was featured on NewsWatch as part of its monthly ... applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... world, people may find themselves in dangerous situations where they ... but some situations can be avoided if there was an ...
(Date:4/18/2015)... April 18, 2015 PHOENIX, ARIZONA – ... along with 11 other secure destruction professionals across the ... Specialists (CSDS). He will now display “CSDS” as a ... offered before the National Association of Information Destruction 2015 ... another Grapevine, Texas. Of the 20 people who took ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2
... RAISE AWARENESS THAT ADDICTION IS A,CHRONIC, TREATABLE DISEASE ... A PUBLIC RALLY IN NYC ON SEPTEMBER 27TH, ... 16 A&E Network today announced the,launch of ... help raise awareness that addiction is a treatable ...
... UNION COUNTY, Pa., Sept. 16 The ... Pennsylvania, is one,of the first recipients of ... FOUND was developed to counter the rise ... Project Lifesaver is a nationwide tracking program ...
... to diagnose location of defects, study says , , ... contribute to hearing loss in children can be detected ... records of hundreds of children diagnosed with sensorineural (related ... computed tomography (CT) and X-rays, is often used to ...
... Food and Drug Administration (FDA), Scott Mandell, CEO, President ... manufacturer of allergy-friendly and gluten-free foods, provided comments at ... of allergens in foods. Mandell cautioned that current labeling ... and other special diet consumers. , ...
... issue campaign aimed,at strengthening and reauthorizing the State Children,s ... Health Care for,Kids, a new, non-partisan organization of labor ... assure that every American child gets,the high quality health ... Kids has launched a bipartisan TV and direct mail,campaign ...
... September 16, 2008 Studies published in a special issue ... Policy by the University of California Press reveal ... behavior in teenagers, provide inaccurate information about condoms, and ... MD, MPH, professor and chair of the Heilbrunn Department ...
Cached Medicine News:Health News:A&E Network Partners with Leading Federal Agencies and Non-Profit Organizations To Launch The Recovery Project 2Health News:A&E Network Partners with Leading Federal Agencies and Non-Profit Organizations To Launch The Recovery Project 3Health News:National Autism Association's 'FOUND' Provides Funds to Union County Sheriff's Office for Project Lifesaver Equipment 2Health News:MRI Detects Soft Tissue Damage Affecting Kids' Hearing 2Health News: Enjoy Life Foods CEO Tells FDA Grocery Stores Remain A Dangerous Minefield for Food Allergic, Food Intolerant and Celiac Shoppers 2Health News: Enjoy Life Foods CEO Tells FDA Grocery Stores Remain A Dangerous Minefield for Food Allergic, Food Intolerant and Celiac Shoppers 3Health News: Enjoy Life Foods CEO Tells FDA Grocery Stores Remain A Dangerous Minefield for Food Allergic, Food Intolerant and Celiac Shoppers 4Health News:Multi-million Dollar Campaign for Kids' Health Program is Launched 2Health News:Multi-million Dollar Campaign for Kids' Health Program is Launched 3Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 2Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 3Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 4
(Date:4/17/2015)... - The issue: In consultation ... lot (lot 710535) of Clavulin-400 (70mL) after receiving a complaint ... in one bottle of the  product. No other lots of ... Clavulin-400 is an oral antibiotic used in adults and children ... Clavulin-400 comes as a powder in bottles and is mixed ...
(Date:4/17/2015)... , April 17, 2015 Contego ... Integrated Embolic Protection™ filter platform for angioplasty balloon ... a $5.6 million Series B financing round led ... firm with a focus on medical devices, biopharmaceuticals, ... round also included Mountain Group Partners, Lookout Capital ...
(Date:4/17/2015)... HILL, N.C. , April 17, 2015  Regulatory ... the newly released bipartisan discussion draft called "21 st ... document is planned to be taken up by Congress ... how pharmaceutical and medical device products are developed and ... For that reason, many companies have begun to consider ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... Alcon, Inc. (NYSE: ACL ) and its ... today that Alcon has begun treating patients in a Phase ... for viral conjunctivitis, a type of "pink eye". Conjunctivitis ... and children, leading to more than four million doctor and ...
... and BRISTOL, Tenn., July 2 Acura Pharmaceuticals, Inc. (Nasdaq: ... KG ) announced today that the U.S. Food and ... the New Drug Application (NDA) for Acurox (oxycodone HC1, USP ... for the relief of moderate-to-severe pain. , ...
Cached Medicine Technology:Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 2Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 3Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 4Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: